These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7737006)

  • 21. Sedation from H1 antagonists: evaluation methods and experimental results.
    Passalacqua G; Scordamaglia A; Ruffoni S; Parodi MN; Canonica GW
    Allergol Immunopathol (Madr); 1993; 21(2):79-83. PubMed ID: 8101691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safe driving reminders.
    Gustaitis J
    Diabetes Self Manag; 2003; 20(2):24-5. PubMed ID: 12715731
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetic overview of oral second-generation H1 antihistamines.
    González MA; Estes KS
    Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug side effects and their prevention].
    Hautarzt; 1997 Aug; 48(8 Suppl):3-4. PubMed ID: 9378645
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug interactions with the nonsedating antihistamines.
    Ament PW; Paterson A
    Am Fam Physician; 1997 Jul; 56(1):223-31. PubMed ID: 9225677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seldane approval may be withdrawn by FDA.
    AIDS Patient Care STDS; 1997 Jun; 11(3):197-8. PubMed ID: 11361802
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical proarrhythmias induced by anti-arrhythmic drugs, non-cardiovascular agents and implantable cardioverter-defibrillators].
    Fazekas T; Liszkai G
    Orv Hetil; 2002 Jan; 143(2):61-9. PubMed ID: 11868450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of new H1-receptor antagonists on cardiovascular system].
    Pietrzkowicz M; Grzelewska-Rzymowska I
    Pol Merkur Lekarski; 1998 Dec; 5(30):360-2. PubMed ID: 10101525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased antihistamine metabolism.
    Kemp JP
    Ann Allergy; 1992 Dec; 69(6):533. PubMed ID: 1361723
    [No Abstract]   [Full Text] [Related]  

  • 31. Special drug communication teleconference. August 7, 1992.
    Ear Nose Throat J; 1992 Sep; 71(9):383-4, 387-90. PubMed ID: 1425376
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fexofenadine: a antihistaminic. Review of its practical characteristics].
    Caballero E; Ocaña I; Azanza JR; Sádaba B
    Rev Med Univ Navarra; 1999; 43(2):93-7. PubMed ID: 11256010
    [No Abstract]   [Full Text] [Related]  

  • 33. The nonsedating antihistamine scare.
    Conti CR
    Clin Cardiol; 1994 Jan; 17(1):1. PubMed ID: 8149675
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug interactions and lethal drug combinations.
    Richens A
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():94-8. PubMed ID: 60351
    [No Abstract]   [Full Text] [Related]  

  • 35. The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective.
    Shaikh WA
    J Indian Med Assoc; 2000 Jul; 98(7):397-9. PubMed ID: 11143865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interactions between drugs and food].
    D'Anna A
    Minerva Med; 1973 Mar; 64(12):573-8. PubMed ID: 4144401
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug interactions, cardiac toxicity, and terfenadine: from bench to clinic?
    Flockhart DA
    J Clin Psychopharmacol; 1996 Apr; 16(2):101-3. PubMed ID: 8690824
    [No Abstract]   [Full Text] [Related]  

  • 38. Terfenadine and SSRIs.
    Tafler G
    CMAJ; 1997 Oct; 157(8):1019. PubMed ID: 9347771
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of astemizole in a large group practice.
    Craig TJ; Greenwald M; Kauffmann V; Craig J
    J Am Osteopath Assoc; 1996 Jun; 96(6):352-4. PubMed ID: 8690622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDA announces plan to halt marketing of terfenadine.
    Am J Health Syst Pharm; 1997 Feb; 54(4):342. PubMed ID: 9043551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.